Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act
Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25
Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines
State opioid response (SOR) Grant funding for FY24 and FY25
Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25
NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone
FAA reauthorization - increasing access to naloxone
HANDS Act - H.R. 5506
SAVE Act of 2023 - H.R. 6161
Overdose Reversal Medication (ORM) Act - H.R. 6243
Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948
Duration: November 1, 2007
to
December 31, 2008
General Issues: Homeland Security , Disaster Planning/Emergencies , Budget/Appropriations , Health Issues , Medical/Disease Research/Clinical Labs
Spending: about $2,930,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2007: U.S. Senate, House of Representatives, U.S. Senate,, Homeland Security - Dept of (DHS), Federal Emergency Management Agency (FEMA), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), Y
Y
Department of Defense
Department of Health and Human Services
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on April 22.
Original Filing: 301576315.xml
Lobbying Issues
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act
Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25
Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines
State opioid response (SOR) Grant funding for FY24 and FY25
Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25
NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone
FAA reauthorization - increasing access to naloxone
HANDS Act - H.R. 5506
SAVE Act of 2023 - H.R. 6161
Overdose Reversal Medication (ORM) Act - H.R. 6243
Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
4th Quarter, 2023
In Q4, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Jan. 22.
Original Filing: 301540630.xml
Lobbying Issues
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act
Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24
Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines
State opioid response (SOR) Grant funding for FY24
Substance Abuse and Mental Health Block Grant (SABG) funding for FY24
NDAA for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone
FAA reauthorization - increasing access to naloxone
HANDS Act - H.R. 5506
SAVE Act of 2023 - H.R. 6161
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
3rd Quarter, 2023
In Q3, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Oct. 20, 2023.
Original Filing: 301514419.xml
Lobbying Issues
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act
Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24
Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines
State opioid response (SOR) Grant funding for FY24
Substance Abuse and Mental Health Block Grant (SABG) funding for FY24
NDAA for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone
FAA reauthorization - increasing access to naloxone
HANDS Act - H.R. 5506
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
2nd Quarter, 2023
In Q2, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on July 20, 2023.
Original Filing: 301491581.xml
Lobbying Issues
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act
Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24
Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines
State opioid response (SOR) Grant funding for FY24
Substance Abuse and Mental Health Block Grant (SABG) funding for FY24
NDAA for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone
FAA reauthorization - increasing access to naloxone
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
1st Quarter, 2023
In Q1, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on April 20, 2023.
Original Filing: 301464838.xml
Lobbying Issues
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act
Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield
Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines
State opioid response (SOR) Grant funding
Substance Abuse and Mental Health Block Grant (SABG) funding
NDAA for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
4th Quarter, 2022
In Q4, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Jan. 19, 2023.
Original Filing: 301435981.xml
Lobbying Issues
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone
HR 2617 - Consolidated Appropriations Act, 2023 (Omnibus)
HR 1437 - Further Continuing Appropriations and Extensions Act
State Opioid Response (SOR) Grants funding
H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021
Substance Abuse and Mental Health Block Grant (SABG) funding
H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act
Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines
H.R 2366; S.1457 - Stop Fentanyl Act
HR 7681 - Preventing Overdoses and Saving Lives Act 2.0
HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022
S. 3799 - PREVENT Pandemics Act
Issues related to the development, manufacture, and distribution of coronavirus vaccines.
HR 3263 Outreach - DHS Medical Countermeasures Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
3rd Quarter, 2022
In Q3, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Oct. 20, 2022.
Original Filing: 301418831.xml
Lobbying Issues
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone
HR 6833 - House and Senate appropriations for FY 2023
State Opioid Response (SOR) Grants funding
H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021
Substance Abuse and Mental Health Block Grant (SABG) funding
H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act
Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines
H.R 2366; S.1457 - Stop Fentanyl Act
H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021
HR 7681 - Preventing Overdoses and Saving Lives Act 2.0
HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022
S. 3799 - PREVENT Pandemics Act
Issues related to the development, manufacture, and distribution of coronavirus vaccines.
HR 3263 Outreach - DHS Medical Countermeasures Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
2nd Quarter, 2022
In Q2, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on July 20, 2022.
Original Filing: 301391234.xml
Lobbying Issues
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone
House and Senate appropriations for FY 2023
State Opioid Response (SOR) Grants funding
H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021
Substance Abuse and Mental Health Block Grant (SABG) funding
H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act
Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines
H.R 2366; S.1457 - Stop Fentanyl Act
H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021
HR 7681 - Preventing Overdoses and Saving Lives Act 2.0
HR 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022
S. 3799 - PREVENT Pandemics Act
Issues related to the development, manufacture, and distribution of coronavirus vaccines.
HR 3263 Outreach - DHS Medical Countermeasures Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
1st Quarter, 2022
In Q1, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on April 20, 2022.
Original Filing: 301370685.xml
Lobbying Issues
H.R. 2471 - Consolidated Appropriations Act, 2022
Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act
NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone
State Opioid Response (SOR) Grants funding
H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021
Substance Abuse and Mental Health Block Grant (SABG) funding
H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act
Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines
H.R 2366; S.1457 - Stop Fentanyl Act
H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021
Issues related to the development, manufacture, and distribution of coronavirus vaccines.
HR 3263 Outreach - DHS Medical Countermeasures Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
4th Quarter, 2021
In Q4, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Jan. 20, 2022.
Original Filing: 301335775.xml
Lobbying Issues
Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act
NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone
State Opioid Response (SOR) Grants funding
H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021
Substance Abuse and Mental Health Block Grant (SABG) funding
H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act
Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines
H.R 2366; S.1457 - Stop Fentanyl Act
H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021
Issues related to the development, manufacture, and distribution of coronavirus vaccines.
HR 3263 Outreach - DHS Medical Countermeasures Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
3rd Quarter, 2021
In Q3, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Oct. 20, 2021.
Original Filing: 301314097.xml
Lobbying Issues
State Opioid Response Grants funding
Substance Abuse and Mental Health Block Grant funding
CARA 3.0 - Comprehensive Addiction and Recovery Act
Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines
H.R. 2379 The State Opioid Response Grant Authorization Act of 2021
Appropriations funding for Fiscal Year 2022
NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone
S.4231 - Preparing for the Next Pandemic Act
H.R 2366 S.1457 - Stop Fentanyl Act
H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021
Issues related to the development, manufacture, and distribution of coronavirus vaccines.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
2nd Quarter, 2021
In Q2, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on July 20, 2021.
Original Filing: 301290250.xml
Lobbying Issues
State Opioid Response Grants funding
Substance Abuse and Mental Health Block Grant funding
CARA 3.0 - Comprehensive Addiction and Recovery Act
Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder
Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines
H.R. 2379 The State Opioid Response Grant Authorization Act of 2021
Appropriations funding for Fiscal Year 2022
NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone
S.4231 - Preparing for the Next Pandemic Act
H.R 2366 S.1457 - Stop Fentanyl Act
Issues related to the development, manufacture, and distribution of coronavirus vaccines.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
1st Quarter, 2021
In Q1, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on April 20, 2021.
Original Filing: 301266489.xml
Lobbying Issues
State Opioid Response Grants funding
Substance Abuse and Mental Health Block Grant funding
CARA 3.0 - Comprehensive Addiction and Recovery Act
Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder
Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines
H.R. 2379 The State Opioid Response Grant Authorization Act of 2021
Appropriations funding for Fiscal Year 2022
NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone
S.4231 - Preparing for the Next Pandemic Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
4th Quarter, 2020
In Q4, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Jan. 20, 2021.
Original Filing: 301242580.xml
Lobbying Issues
State Opioid Response Grants funding for FY 2021
H.R. 6395, NDAA for Fiscal Year 2021- provisions related to biological and chemical defense and access to naloxone
Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder
Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines
H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign.
H.R. 2466 The State Opioid Response Grant Authorization Act
H.R. 7574 - Strengthening Americas Strategic National Stockpile Act of 2020
HEROES Act - H.R. 8406 - The Heroes Act
S.4231 - Preparing for the Next Pandemic Act
HEALS Act
H.R. 14, the Commitment to Defeat the Virus and Keep America Healthy Act
H.R. 133, Consolidated Appropriations Act 2021
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
3rd Quarter, 2020
In Q3, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Oct. 20, 2020.
Original Filing: 301222280.xml
Lobbying Issues
Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government.
State Opioid Response Grants funding for FY 2021.
NDAA - provisions related to biological and chemical defense.
Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder
Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines.
H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker.
H.R. 2466 The State Opioid Response Grant Authorization Act
H.R. 7574 - Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce)
HEROES Act - H.R.8406 - The Heroes Act
S.4231 - Preparing for the Next Pandemic Act
HEALS Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
2nd Quarter, 2020
In Q2, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on July 20, 2020.
Original Filing: 301200181.xml
Lobbying Issues
Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
State Opioid Response Grants funding for FY 2021
NDAA - provisions related to biological and chemical defense
Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder
Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
1st Quarter, 2020
In Q1, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on April 20, 2020.
Original Filing: 301178176.xml
Lobbying Issues
H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations, including provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
NDAA - provisions related to biological and chemical defense
Issues related to Priority Review Voucher programs
Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
4th Quarter, 2019
In Q4, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Jan. 21, 2020.
Original Filing: 301128945.xml
Lobbying Issues
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
NDAA - provisions related to biological and chemical defense
Department of Defense appropriations for Medical Countermeasures
FDA regulatory issues
Issues related to Priority Review Voucher programs
Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
3rd Quarter, 2019
In Q3, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Oct. 21, 2019.
Original Filing: 301078528.xml
Lobbying Issues
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
NDAA - provisions related to biological and chemical defense
Department of Defense appropriations for Medical Countermeasures
FDA regulatory issues
Issues related to Priority Review Voucher programs
Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
2nd Quarter, 2019
In Q2, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on July 22, 2019.
Original Filing: 301058305.xml
Lobbying Issues
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
NDAA - provisions related to biological and chemical defense
Department of Defense appropriations for Medical Countermeasures
FDA regulatory issues
Issues related to Priority Review Voucher programs
Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
1st Quarter, 2019
In Q1, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on April 22, 2019.
Original Filing: 301035920.xml
Lobbying Issues
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
NDAA - provisions related to biological and chemical defense
Department of Defense appropriations for Medical Countermeasures
FDA regulatory issues
Issues related to Priority Review Voucher programs
Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
4th Quarter, 2018
In Q4, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Jan. 22, 2019.
Original Filing: 301014636.xml
Lobbying Issues
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
NDAA - provisions related to biological and chemical defense
Department of Defense appropriations for Medical Countermeasures
H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
FDA regulatory issues
Issues related to Priority Review Voucher programs
Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
3rd Quarter, 2018
In Q3, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Oct. 22, 2018.
Original Filing: 300996572.xml
Lobbying Issues
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
NDAA - provisions related to biological and chemical defense
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
2nd Quarter, 2018
In Q2, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on July 20, 2018.
Original Filing: 300976988.xml
Lobbying Issues
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
NDAA - provisions related to biological and chemical defense
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
1st Quarter, 2018
In Q1, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on April 20, 2018.
Original Filing: 300956199.xml
Lobbying Issues
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
NDAA - provisions related to biological and chemical defense
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
4th Quarter, 2017
Navigators Global LLC (Formerly DC Navigators, LLC) amended a lobbying report for representation of Emergent BioSolutions Inc. in Q42017 on Jan. 24, 2018.
Original Filing: 300938275.xml
Lobbying Issues
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
NDAA - provisions related to biological and chemical defense
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
4th Quarter, 2017
In Q4, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $30,000. The report was filed on Jan. 22, 2018.
Original Filing: 300936126.xml
Lobbying Issues
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
NDAA - provisions related to biological and chemical defense
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
3rd Quarter, 2017
Navigators Global LLC (Formerly DC Navigators, LLC) amended a lobbying report for representation of Emergent BioSolutions Inc. in Q32017 on Oct. 17, 2017.
Original Filing: 300905704.xml
Lobbying Issues
FY 2018 Appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures.
Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government.
Re-authorization of the Pandemic and All-Hazards Preparedness Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
3rd Quarter, 2017
In Q3, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $30,000. The report was filed on Oct. 12, 2017.
Original Filing: 300903396.xml
Lobbying Issues
FY 2018 Appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures.
Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
2nd Quarter, 2017
In Q2, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $30,000. The report was filed on July 14, 2017.
Original Filing: 300884642.xml
Lobbying Issues
FY 2018 Appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures.
Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
1st Quarter, 2017
In Q1, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $30,000. The report was filed on April 19, 2017.
Original Filing: 300869041.xml
Lobbying Issues
FY 2017 and FY 2018 Appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures.
Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Budget/Appropriations
4th Quarter, 2016
Navigators Global LLC (Formerly DC Navigators, LLC) amended a lobbying report for representation of Emergent BioSolutions Inc. in Q42016 on Jan. 18, 2017.
Original Filing: 300849267.xml
Lobbying Issues
FY'16 DHS Appropriations Act
Draft FY'16 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
HR 1300 & S 1915 First Responder Anthrax Preparedness Act
HR 3299 - Strengthening Public Health Emergency Response Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY'16 DHS Appropriations Act
Draft FY'16 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
HR 1300 & S 1915 - First Responder Anthrax Preparedness Act
HR 3299 - Strengthening Public Health Emergency Response Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies Health Issues Budget/Appropriations
4th Quarter, 2016
In Q4, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Jan. 17, 2017.
Original Filing: 300847393.xml
Lobbying Issues
FY'16 DHS Appropriations Act
Draft FY'16 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
HR 1300 & S 1915 First Responder Anthrax Preparedness Act
HR 3299 - Strengthening Public Health Emergency Response Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY'16 DHS Appropriations Act
Draft FY'16 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
HR 1300 & S 1915 - First Responder Anthrax Preparedness Act
HR 3299 - Strengthening Public Health Emergency Response Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies Health Issues Budget/Appropriations
3rd Quarter, 2016
In Q3, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Oct. 14, 2016.
Original Filing: 300827786.xml
Lobbying Issues
FY'16 DHS Appropriations Act
Draft FY'16 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
HR 1300 & S 1915 First Responder Anthrax Preparedness Act
HR 3299 - Strengthening Public Health Emergency Response Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY'16 DHS Appropriations Act
Draft FY'16 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
HR 1300 & S 1915 - First Responder Anthrax Preparedness Act
HR 3299 - Strengthening Public Health Emergency Response Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies Health Issues Budget/Appropriations
2nd Quarter, 2016
In Q2, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on July 7, 2016.
Original Filing: 300807206.xml
Lobbying Issues
FY'16 DHS Appropriations Act
Draft FY'16 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
HR 1300 & S 1915 First Responder Anthrax Preparedness Act
HR 3299 - Strengthening Public Health Emergency Response Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY'16 DHS Appropriations Act
Draft FY'16 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
HR 1300 & S 1915 - First Responder Anthrax Preparedness Act
HR 3299 - Strengthening Public Health Emergency Response Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies Health Issues Budget/Appropriations
1st Quarter, 2016
In Q1, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on April 18, 2016.
Original Filing: 300793660.xml
Lobbying Issues
FY'16 DHS Appropriations Act
Draft FY'16 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
HR 1300 & S 1915 First Responder Anthrax Preparedness Act
HR 3299 - Strengthening Public Health Emergency Response Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY'16 DHS Appropriations Act
Draft FY'16 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
HR 1300 & S 1915 - First Responder Anthrax Preparedness Act
HR 3299 - Strengthening Public Health Emergency Response Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies Health Issues Budget/Appropriations
4th Quarter, 2015
In Q4, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Jan. 20, 2016.
Original Filing: 300778472.xml
Lobbying Issues
FY'16 DHS Appropriations Act
Draft FY'16 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
HR 1300 & S 1915 First Responder Anthrax Preparedness Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY'16 DHS Appropriations Act
Draft FY'16 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
HR 1300 & S 1915 - First Responder Anthrax Preparedness Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies Health Issues Budget/Appropriations
3rd Quarter, 2015
In Q3, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Oct. 20, 2015.
Original Filing: 300762009.xml
Lobbying Issues
FY'16 DHS Appropriations Act
Draft FY'16 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
HR 1300 First Responder Anthrax Preparedness Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Health Issues Budget/Appropriations
2nd Quarter, 2015
In Q2, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on July 16, 2015.
Original Filing: 300737117.xml
Lobbying Issues
FY'16 DHS Appropriations Act
Draft FY'16 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
HR 1300 First Responder Anthrax Preparedness Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Health Issues Budget/Appropriations
1st Quarter, 2015
In Q1, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on April 20, 2015.
Original Filing: 300725219.xml
Lobbying Issues
FY'15 DHS Appropriations Act
FY'16 DHS Appropriations Act
Draft FY'16 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
HR 1300 First Responder Anthrax Preparedness Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Homeland Security Disaster Planning/Emergencies Health Issues Budget/Appropriations
4th Quarter, 2014
In Q4, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Jan. 16, 2015.
Original Filing: 300698568.xml
Lobbying Issues
FY'15 DHS Appropriations Act
Draft FY'15 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
HR 5620 First Responder Anthrax Preparedness Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY'15 DHS Appropriations Act
DRAFT FY'15 Labor HHS Appropriations Bill - Provisions related to development, acquisition and stockpiling of biodefense vaccines
HR 5620 First Responder Anthrax Preparedness Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies Health Issues Budget/Appropriations
3rd Quarter, 2014
In Q3, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Oct. 16, 2014.
Original Filing: 300678185.xml
Lobbying Issues
FY'15 DHS Appropriations Act, Draft FY'15 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines.
HR 5620 First Responder Anthrax Preparedness Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
FY'15 DHS Appropriations Act, DRAFT FY'15 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies Health Issues Budget/Appropriations
2nd Quarter, 2014
In Q2, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on July 11, 2014.
Original Filing: 300655262.xml
Lobbying Issues
FY'15 DHS Appropriations Act, Draft FY'15 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
FY'15 DHS Appropriations Act, DRAFT FY'15 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
FY'15 DHS Appropriations Act, DRAFT FY'15 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Health Issues Budget/Appropriations
1st Quarter, 2014
In Q1, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on April 21, 2014.
Original Filing: 300646492.xml
Lobbying Issues
H.R. 3547 - Consolidated Appropriations Act, 2014, Draft FY'15 DHS Appropriations Act, Draft FY'15 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
H.R. 3547 - Consolidated Appropriations Act, 2014, DRAFT FY'15 DHS Appropriations Act, DRAFT FY'15 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
H.R. 3547 - Consolidated Appropriations Act, 2014, DRAFT FY'15 DHS Appropriations Act, DRAFT FY'15 Labor HHS Appropriations Bill -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Health Issues Budget/Appropriations
4th Quarter, 2013
In Q4, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Jan. 21, 2014.
Original Filing: 300623984.xml
Lobbying Issues
HR 2217 - FY'14 DHS Appropriations Act, S. 1284 - FY'14 Labor HHS Appropriations Bill, HJ Res 59 - Continuing Appropriations Resolution -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
HR 2217 - FY'14 DHS Appropriations Act, S. 1284 - FY'14 Labor HHS Appropriations Bill, HJ Res 59 - Continuing Appropriations Resolution -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
HR 2217 - FY'14 DHS Appropriations Act, S. 1284 - FY'14 Labor HHS Appropriations Bill, HJ Res 59 - Continuing Appropriations Resolution -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Health Issues Budget/Appropriations
3rd Quarter, 2013
In Q3, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Oct. 21, 2013.
Original Filing: 300604894.xml
Lobbying Issues
HR 2217 - FY'14 DHS Appropriations Act, Draft FY'14 Labor HHS Appropriations Bill, HJ Res 59 - Continuing Appropriations Resolution -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
HR 2217 - FY'14 DHS Appropriations Act, Draft FY'14 Labor HHS Appropriations Bill, HJ Res 59 - Continuing Appropriations Resolution -- Provisions related to development, acquisition and stockpiling of biodefense vaccines
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Disaster Planning/Emergencies Health Issues Budget/Appropriations
2nd Quarter, 2013
In Q2, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on July 19, 2013.
Original Filing: 300578296.xml
Lobbying Issues
H.R.307 and S. 242 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 - entire bill reauthorizing funding and strengthening bioterorism preparedness programs, including Biomedical Advanced Research & Development Authority (BARDA) and the development of medical countermeasures (MCMs);FY 2014 Department of Homeland Security appropriations bill - provisions related to development, acquisition and stockpiling of biodefense vaccines;
FY 2014 Departments of Health and Human Services and Education, and related agencies appropriations bill - provisions related to development, acquisition and stockpiling of biodefense vaccines
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
H.R.307 and S. 242 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 - entire bill reauthorizing funding and strengthening bioterorism preparedness programs, including Biomedical Advanced Research & Development Authority (BARDA) and the development of medical countermeasures (MCMs);FY 2014 Department of Homeland Security appropriations bill - provisions related to development, acquisition and stockpiling of biodefense vaccines;
FY 2014 Departments of Health and Human Services and Education, and related agencies appropriations bill - provisions related to development, acquisition and stockpiling of biodefense vaccines
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Disaster Planning/Emergencies Health Issues Budget/Appropriations
1st Quarter, 2013
In Q1, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on April 18, 2013.
Original Filing: 300553068.xml
Lobbying Issues
HR 5855 and S3216 - Department of Homeland Security Appropriations Act -- Provisions related to development, acquisition and stockpiling of biodefense vaccines.HR 2356, WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
S 3295 - Labor HHS Appropriations Act for FY'13 - provisions relating to development, acquisition and stockpiling of biodefense vaccines.
HR 2405 and S 1855, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - All provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
HR 5855 and S 3216 - Department of Homeland Security Appropriations Act -- Provisions related to development, acquisition and stockpiling of biodefense vaccines.HR 2356, WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
S 3295- Labor HHS Appropriations Act for FY'13 - provisions relating to development, acquisition and stockpiling of biodefense vaccines.
HR 2405 and S. 1855, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - All provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Disaster Planning/Emergencies Health Issues
Lobbying Issues
HR 5855 and S3216 - Department of Homeland Security Appropriations Act -- Provisions related to development, acquisition and stockpiling of biodefense vaccines.HR 2356, WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
S 3295- Labor HHS Appropriations Act for FY'13 - provisions relating to development, acquisition and stockpiling of biodefense vaccines.
HR 2405 and S. 1855, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - All provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2012
In Q4, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Jan. 22, 2013.
Original Filing: 300540451.xml
Lobbying Issues
HR 5855 and S3216 - Department of Homeland Security Appropriations Act -- Provisions related to development, acquisition and stockpiling of biodefense vaccines.HR 2356, WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
S 3295 - Labor HHS Appropriations Act for FY'13 - provisions relating to development, acquisition and stockpiling of biodefense vaccines.
HR 2405 and S 1855, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - All provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
HR 5855 and S 3216 - Department of Homeland Security Appropriations Act -- Provisions related to development, acquisition and stockpiling of biodefense vaccines.HR 2356, WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
S 3295- Labor HHS Appropriations Act for FY'13 - provisions relating to development, acquisition and stockpiling of biodefense vaccines.
HR 2405 and S. 1855, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - All provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Disaster Planning/Emergencies Health Issues
Lobbying Issues
HR 5855 and S3216 - Department of Homeland Security Appropriations Act -- Provisions related to development, acquisition and stockpiling of biodefense vaccines.HR 2356, WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
S 3295- Labor HHS Appropriations Act for FY'13 - provisions relating to development, acquisition and stockpiling of biodefense vaccines.
HR 2405 and S. 1855, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - All provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2012
In Q3, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on Oct. 22, 2012.
Original Filing: 300519333.xml
Lobbying Issues
HR 5855 and S3216 - Department of Homeland Security and Labor HHS Appropriations Acts for FY'13 -- Provisions related to development, acquisition and stockpiling of biodefense vaccines.HR 2356, WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
S 3295- provisions relating to development, acquisition and stockpiling of biodefense vaccines.
HR 2405 and S 1855, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - All provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
HR 5855 and S 3216 - Department of Homeland Security and Labor HHS Appropriations Acts for FY'13 -- Provisions related to development, acquisition and stockpiling of biodefense vaccines.HR 2356, WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
S 3295- provisions relating to development, acquisition and stockpiling of biodefense vaccines.
HR 2405 and S. 1855, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - All provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Disaster Planning/Emergencies Health Issues
Lobbying Issues
HR 5855 and S3216 - Department of Homeland Security and Labor HHS Appropriations Acts for FY'13 -- Provisions related to development, acquisition and stockpiling of biodefense vaccines.HR 2356, WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
S 3295- provisions relating to development, acquisition and stockpiling of biodefense vaccines.
HR 2405 and S. 1855, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - All provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2012
In Q2, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on July 20, 2012.
Original Filing: 300496890.xml
Lobbying Issues
HR 5855 and S3216 - Department of Homeland Security and Labor HHS Appropriations Acts for FY'13 -- Provisions related to development, acquisition and stockpiling of biodefense vaccines.HR 2356, WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
S 3295- provisions relating to development, acquisition and stockpiling of biodefense vaccines.
HR 2405 and S 1855, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - All provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
HR 5855 and S 3216 - Department of Homeland Security and Labor HHS Appropriations Acts for FY'13 -- Provisions related to development, acquisition and stockpiling of biodefense vaccines.HR 2356, WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
S 3295- provisions relating to development, acquisition and stockpiling of biodefense vaccines.
HR 2405 and S. 1855, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - All provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Disaster Planning/Emergencies Health Issues
Lobbying Issues
HR 5855 and S3216 - Department of Homeland Security and Labor HHS Appropriations Acts for FY'13 -- Provisions related to development, acquisition and stockpiling of biodefense vaccines.HR 2356, WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
S 3295- provisions relating to development, acquisition and stockpiling of biodefense vaccines.
HR 2405 and S. 1855, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - All provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2012
In Q1, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on April 20, 2012.
Original Filing: 300471421.xml
Lobbying Issues
Department of Homeland Security and Labor HHS Appropriations Acts for FY'13 -- Provisions related to development, acquisition and stockpiling of biodefense vaccines.HR 2356, WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation and re-authorization of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
HR 2405 and S 1855, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - All provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Department of Homeland Security and Labor HHS Appropriations Acts for FY'13 -- Provisions related to development, acquisition and stockpiling of biodefense vaccines.HR 2356, WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation and re-authorization of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
HR 2405 and S. 1855, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - All provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Disaster Planning/Emergencies Health Issues Budget/Appropriations
4th Quarter, 2011
In Q4, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $40,000. The report was filed on Jan. 20, 2012.
Original Filing: 300449394.xml
Lobbying Issues
HR 2055 - Consolidated Appropriations Act of 2012, Divisions D and F - Provisions related to development, acquisition and stockpiling of biodefense vaccines.HR 2356, WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation and re-authorization of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
HR 2405, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - All provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
HR 2055 - Consolidated Appropriations Act of 2012, Divisions D and F - Provisions related to development, acquisition and stockpiling of biodefense vaccines.HR 2356, WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation and re-authorization of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
HR 2405, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - All provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Disaster Planning/Emergencies Health Issues
3rd Quarter, 2011
In Q3, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $30,000. The report was filed on Oct. 20, 2011.
Original Filing: 300427874.xml
Lobbying Issues
Department of Labor, Health & Human Services and Education Appropriations Act for 2011 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
HR 2017, Department of Homeland Security Appropriations Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.HR 2356, WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
HR 2405, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - All provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Department of Labor, Health & Human Services and Education Appropriations Act for 2011 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
HR 2017, Department of Homeland Security Appropriations Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.HR 2356, WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
HR 2405, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - All provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
FY'12 Department of Labor, Health & Human Services and Education Appropriations Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
HR 2017, Department of Homeland Security Appropriations Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.HR 2356, WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
HR 2405, Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - All provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2011
In Q2, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $30,000. The report was filed on July 20, 2011.
Original Filing: 300400871.xml
Lobbying Issues
Department of Labor, Health & Human Services and Education Appropriations Act for 2011 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Department of Homeland Security Appropriations Act, 2011 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Department of Labor, Health & Human Services and Education Appropriations Act for 2011 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Department of Homeland Security Appropriations Act, 2011 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Disaster Planning/Emergencies Health Issues
1st Quarter, 2011
In Q1, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $30,000. The report was filed on April 20, 2011.
Original Filing: 300373931.xml
Lobbying Issues
Department of Labor, Health & Human Services and Education Appropriations Act for 2011 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Department of Homeland Security Appropriations Act, 2011 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Department of Labor, Health & Human Services and Education Appropriations Act for 2011 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Department of Homeland Security Appropriations Act, 2011 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.WMD Prevention and Preparedness Act - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Disaster Planning/Emergencies Health Issues
4th Quarter, 2010
In Q4, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $30,000. The report was filed on Dec. 31, 2010.
Original Filing: 300334434.xml
Lobbying Issues
Labor HHS and DHS Appropriations Acts for FY 2011, provisions related to development, acquisition and stockpilinig of biodefense vaccines.
Implementation of the Biomedical Advanced Research and Development Authority and Project BioShield relating to stockpiling of biodefense vaccines.S. 1649 and HR 5498, WMD Prevention and Preparedness Act of 2009, provisions related to development, acquisition and stockpilinig of biodefense vaccines.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Homeland Security - Dept of (DHS) Federal Emergency Management Agency (FEMA)
3rd Quarter, 2010
In Q3, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $30,000. The report was filed on Oct. 15, 2010.
Original Filing: 300313662.xml
Lobbying Issues
Labor HHS and DHS Appropriations Acts for FY 2011, provisions related to development, acquisition and stockpilinig of biodefense vaccines.
Implementation of the Biomedical Advanced Research and Development Authority and Project BioShield relating to stockpiling of biodefense vaccines.S. 1649 and HR 5498, WMD Prevention and Preparedness Act of 2009, provisions related to development, acquisition and stockpilinig of biodefense vaccines.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Homeland Security - Dept of (DHS) Federal Emergency Management Agency (FEMA)
2nd Quarter, 2010
In Q2, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $30,000. The report was filed on July 20, 2010.
Original Filing: 300299760.xml
Lobbying Issues
Labor HHS and DHS Appropriations Acts for FY 2011, provisions related to development, acquisition and stockpilinig of biodefense vaccines.
Implementation of the Biomedical Advanced Research and Development Authority and Project BioShield relating to stockpiling of biodefense vaccines.S. 1649 and HR 5498, WMD Prevention and Preparedness Act of 2009, provisions related to development, acquisition and stockpilinig of biodefense vaccines.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Homeland Security - Dept of (DHS) Federal Emergency Management Agency (FEMA)
1st Quarter, 2010
In Q1, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $30,000. The report was filed on April 20, 2010.
Original Filing: 300270868.xml
Lobbying Issues
No Bill Numbers, DHS Appropriations Act for FY 2011, provisions related to development, acquisition and stockpilinig of biodefense vaccines.
Implementation of the Biomedical Advanced Research and Development Authority and Project BioShield relating to stockpiling of biodefense vaccines.S. 1649, WMD Prevention and Preparedness Act of 2009, provisions related to development, acquisition and stockpilinig of biodefense vaccines.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Homeland Security - Dept of (DHS) Federal Emergency Management Agency (FEMA)
4th Quarter, 2009
In Q4, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $30,000. The report was filed on Jan. 20, 2010.
Original Filing: 300246936.xml
Lobbying Issues
HR 3288, Consolidated Appropriations Act, provisions related to development, acquisition and stockpilinig of biodefense vaccines.
HR 2892 and S. 1298, DHS Appropriations Act for 2010, provisions related to development, acquisition and stockpilinig of biodefense vaccines.
S. 1649, WMD Prevention and Preparedness Act of 2009, provisions related to development, acquisition and stockpilinig of biodefense vaccines.
Implementation of the Biomedical Advanced Research and Development Authority and Project BioShield relating to stockpiling of biodefense vaccines.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Homeland Security - Dept of (DHS) Federal Emergency Management Agency (FEMA)
3rd Quarter, 2009
In Q3, Navigators Global LLC (Formerly DC Navigators, LLC) lobbied for Emergent BioSolutions Inc. , earning $30,000. The report was filed on Oct. 20, 2009.
Original Filing: 300219384.xml
Lobbying Issues
Issues relating to the development, acquisition, and stockpiling of biodefense vaccines, No Specific Legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Homeland Security - Dept of (DHS) Federal Emergency Management Agency (FEMA)
2nd Quarter, 2009
In Q2, DC Navigators, LLC lobbied for Emergent BioSolutions Inc. , earning $20,000. The report was filed on July 17, 2009.
Original Filing: 300182128.xml
Lobbying Issues
Issues relating to the development, acquisition, and stockpiling of biodefense vaccines, No Specific Legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Homeland Security - Dept of (DHS) Federal Emergency Management Agency (FEMA)
4th Quarter, 2008
DC Navigators, LLC terminated an engagement in which they represented Emergent BioSolutions Inc. on Jan. 16, 2009.
Original Filing: 300123001.xml
Lobbying Issues
Matters relating to Project Bioshield, No Specific Legislation
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
3rd Quarter, 2008
In Q3, DC Navigators, LLC lobbied for Emergent BioSolutions Inc. , earning $60,000. The report was filed on Oct. 20, 2008.
Original Filing: 300106107.xml
Lobbying Issues
Matters relating to Project Bioshield, No Specific Legislation
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
Lobbying Issues
HR 2638, FY'09 Continuing Appropriations Act
Agencies Lobbied
Office of Management & Budget (OMB)
2nd Quarter, 2008
In Q2, DC Navigators, LLC lobbied for Emergent BioSolutions Inc. , earning $60,000. The report was filed on July 18, 2008.
Original Filing: 300073180.xml
Lobbying Issues
Matters relating to Project Bioshield, No Specific Legislation
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
1st Quarter, 2008
In Q1, DC Navigators, LLC lobbied for Emergent BioSolutions Inc. , earning $50,000. The report was filed on April 21, 2008.
Original Filing: 300052695.xml
Lobbying Issues
Matters relating to Project Bioshield, No Specific Legislation
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
0th Quarter, 2007
In MM, DC NAVIGATORS LLC lobbied for Emergent BioSolutions Inc. , earning $100,000. The report was filed on Aug. 2, 2007.
Original Filing: 200044951.xml
Lobbying Issues
H.R. 5467 FY 2008 Labor - HHS Appropriations Act, provisions relating to Project Bioshield Funding.
H.R. 1 - Implementing the 9/11 Commission Recommendations Act of 2007.
Matters pertaining to the Bioshield Project.
Agencies Lobbied
Y
Y
Department of Defense
Department of Health and Human Services
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate